CBD’s potential impact on Parkinson’s disease: An updated overview
Abstract Background: Parkinson’s disease (PD) is primarily known as a motor disorder; however, its debilitating non-motor symptoms have a significant…
Cannabidiol (CBD)
Case reports of identical twins with developmental and epileptic encephalopathy with STXBP1 gene mutations for whom different CBD supplementations were markedly effective
Abstract Identical twins with intractable epilepsy achieved seizure suppression with CBD. CBD products that proved effective in each patient differed,…
The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review
Abstract Introduction: There is growing recognition of the potential of cannabis to treat various medical conditions and symptoms, such as…
Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder
Abstract Pediatric genetic epilepsies, such as CDKL5 Deficiency Disorder (CDD), are severely debilitating, with early-onset seizures occurring more than ten…
Assessment of the effects of cannabidiol and a CBD-rich hemp extract in Caenorhabditis elegans
Abstract Consumer use of cannabidiol (CBD) is growing, but there are still data gaps regarding its possible adverse effects on…
Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Abstract Cannabidiol (CBD)-containing products are widely marketed as over the counter products. Adverse effects reported in anecdotal consumer reports or…
Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s40122-024-00643-0. Article type: Review Article Keywords: Cannabinoids, Cannabidiol, Tetrahydrocannabinol,…
Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial
Abstract Background: Multiple sclerosis (MS) is an inflammatory and degenerative disease of the central nervous system. More than 90,000 Canadians…
Prenatal broad-spectrum cannabidiol administration prevents an autism-like phenotype in male offspring from a maternal stress/terbutaline rat model
Abstract Recently, the diagnosis of autism spectrum disorder (ASD) has increased from 1 in 150 to every 1 in 36…
Cannabinoid Awareness, Reporting Use to Health Care Providers, and Perceptions Regarding Safety – Pennsylvania, March 2023–April 2023
Abstract Introduction: With the continued societal and policy interest in cannabinoids, the Penn State Harrisburg Center for Survey Research (CSR)…